Loading...

DWTX DOGWOOD THERAPEUTICS INC US FDA Inspections 8-K Filing

DGWD

DWTX

DOGWOOD THERAPEUTICS INC

(DWTX)

2023 8-K

Show Summary

Show Summary

Financial Statements

Compliance Update

Financial Results

Company Acquisition

Quarterly Results

Nasdaq Compliance

Business Combination

Financial Results Announcement

Annual Meeting Results

Public Offering

Results of Operations

Meeting Approval

Financial Results Announcement

Salary Reduction and Stock ...

Letter to Shareholders

Financial Results Announcement

Regulation FD Disclosure

Termination of Sales Agreement

Financial Results Announcement

FDA Review of Chronic Toxic...

Results of Operations and F...

Annual Meeting Results

Compliance regained with Na...

Earnings Reports

Compliance Extension

Corporate Progress Report

Financial Results Announcement

External Links:

Virios Therapeutics announced that the FDA has reviewed their chronic toxicology program and found it adequate to support the safety of IMC-1 for chronic use.

AI Assistant

DOGWOOD THERAPEUTICS INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.